Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer

By Bartsch Rupert   Wenzel Catharina   Gampenrieder Simon   Pluschnig Ursula   Altorjai Gabriela   Rudas Margaretha   Mader Robert   Dubsky Peter   Rottenfusser Andrea   Gnant Michael   Zielinski Christoph   Steger Guenther  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 903-910

Springer Publishing Company

Access to resources Recommend Favorite

Οutcomes for patients who are diagnosed with breast and endometrial cancer

By      

Oncology Letters, Vol. 6, Iss. 4, 2013-01 ,pp. : 1103-1107

Spandidos Publications

Access to resources Recommend Favorite

Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer

By Lidgren Mathias   Wilking Nils   Jonsson Bengt   Rehnberg Clas  

Acta Oncologica, Vol. 47, Iss. 6, 2008-08 ,pp. : 1018-1028

Informa Healthcare

Access to resources Recommend Favorite

Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients

By Bighin Claudia   Pronzato Paolo   Del Mastro Lucia  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 955-957

Future Medicine

Access to resources Recommend Favorite

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study

By Campiglio Manuela   Bufalino Rosaria   Sandri Marco   Ferri Elisa   Aiello Rosa   Matteis Andrea   Mottolese Marcella   Placido Sabino   Querzoli Patrizia   Jirillo Antonio   Bottini Alberto   Fantini Manuela   Bonetti Andrea   Pedani Fulvia   Mauri Maria   Molino Annamaria   Ferro Antonella   Pupa Serenella   Sasso Marianna   Ménard Sylvie   Balsari Andrea   Tagliabue Elda  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 147-154

Springer Publishing Company

Access to resources Recommend Favorite